Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Mylan
|
| gptkbp:acquisitionYear |
2016
|
| gptkbp:country |
gptkb:Sweden
|
| gptkbp:focusArea |
pain management
respiratory diseases allergy treatments |
| gptkbp:foundedYear |
1954
|
| gptkbp:headquartersLocation |
gptkb:Solna,_Sweden
|
| https://www.w3.org/2000/01/rdf-schema#label |
Meda Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
Dymista
Epipen |
| gptkbp:numberOfEmployees |
~2000 (before acquisition)
|
| gptkbp:parentCompany |
gptkb:Mylan
|
| gptkbp:products |
over-the-counter drugs
prescription drugs |
| gptkbp:stockExchange |
Nasdaq Stockholm (before acquisition)
|
| gptkbp:stockSymbol |
MEDA (before acquisition)
|
| gptkbp:website |
https://www.meda.se/
|
| gptkbp:bfsParent |
gptkb:Zyclara
gptkb:Ancobon gptkb:Edluar gptkb:Oramorph |
| gptkbp:bfsLayer |
7
|